M-Sten (Methylstenbolone) UK: What the Research Shows, Liver Findings and Legal Status in 2026

M-Sten (methylstenbolone) explained for UK buyers: a 17-alpha-methylated designer steroid, the anti-doping and case-report literature, liver findings, 2026 legal and WADA status.

4 min readUpdated 18 Sep 2026

Summary of published research for laboratory reference. Products are not for human consumption.

Last updated 18 September 2026 · SARMs Store editorial team. This guide describes published research on a compound sold by SARMs Store strictly for laboratory use. Nothing here is medical advice, a dosing instruction or a recommendation for human consumption.

M-Sten (Methylstenbolone) at a glance

Chemical name 2,17a-dimethyl-5a-androsta-1-en-17b-ol-3-one
Also sold as M-Sten, Methylstenbolone, Ultradrol, Methyl-Sten
Class 17a-methylated steroidal compound (designer steroid); structurally related to methasterone (Superdrol)
Highest evidence Anti-doping metabolite studies and hepatology case reports; no controlled human trial
Aromatisation Does not aromatise (1-ene, 2-methyl A ring)
Format Capsule, 5mg, 90 per bottle
UK status 2026 Not a controlled drug; not a licensed medicine; research use only; WADA S1 prohibited at all times

What M-Sten is

Methylstenbolone is a synthetic androgen first described in a 1960s Searle patent and never developed as a medicine. It is a 2-methyl, 17-alpha-methyl derivative of stenbolone with a double bond at the 1 position. The 17-alpha-methyl group makes it orally active and is the modification associated across the class with cholestatic liver injury; the 2-methyl and 1-ene features resemble methasterone, the compound sold as Superdrol until it was withdrawn and later scheduled in the United States.

M-Sten reached the retail market around 2011 under the name Ultradrol, after methasterone was removed from sale. It was added to the US controlled list by the Designer Anabolic Steroid Control Act of 2014.

Alpha Labs Methylstenbolone M-Sten 5mg 90 Capsules
Research this compound
5mg · 90 caps. Batch certificate published.

What the research shows

There is no controlled human study of methylstenbolone. The primary literature has two strands. The first is analytical: Cavalcanti and colleagues at the Rio de Janeiro anti-doping laboratory published the human urinary metabolite profile in 2013, confirming that the compound is absorbed intact, extensively metabolised, and detectable for sport by the standard steroid screen. Later work from Cologne extended the metabolite list.

The second strand is clinical case reporting. Hepatology journals in the United States and Europe have published a cluster of cases of cholestatic jaundice, some severe, in men who used products labelled as methylstenbolone or Ultradrol, with recovery over months after stopping. The pattern is the same one documented for methasterone, and the mechanism is attributed to the 17-alpha-methyl group. Several of those reports involved products found on analysis to contain undeclared compounds, which again is the argument for batch testing in this category.

Receptor work on the compound itself is sparse. Its structural relatives (methasterone, stenbolone) bind the androgen receptor strongly and do not aromatise, and retail descriptions of M-Sten as a dry, non-aromatising compound rest on that structural inference rather than on measured data.

How M-Sten differs from epistane and trenavar

All three are steroidal and all three are prohibited in sport, but they are different chemistries. Epistane is a 17-alpha-methylated epitiostanol derivative with anti-oestrogenic heritage. Trenavar is a non-methylated 19-nor precursor that must be converted to trenbolone. M-Sten is a 17-alpha-methylated dihydrotestosterone-family compound related to methasterone, which places it with the group carrying the strongest liver signal in the case literature. Researchers comparing the three should weight that difference heavily.

Legal status in the UK, 2026

Methylstenbolone is not listed under the Misuse of Drugs Act 1971, so possession is lawful in the United Kingdom. It is not a licensed medicine; selling or advertising it for human consumption would make it an unlicensed medicinal product, and SARMs Store sells it strictly for laboratory research. It has been Schedule III in the United States since 2014 and is prohibited at all times in sport under WADA S1.1. Country guides: USA, Australia, Canada.

Testing and how to read the certificate

Products sold as M-Sten have a documented record of substitution with methasterone or other compounds, which makes identity testing the whole point of the certificate. It should show identity by HPLC or LC-MS against a methylstenbolone reference standard, a purity figure, and the batch number matching the bottle. Alpha Labs M-Sten is encapsulated in the UK at 5mg per capsule. Every batch is independently tested and its certificate of analysis is published on the product page and on the Lab Testing page. See how to read a certificate of analysis.

Frequently asked questions

Is M-Sten legal in the UK in 2026?

Yes to possess and buy as a research compound; it is not a controlled drug in the UK. It is not a licensed medicine and cannot be sold for human consumption. It is Schedule III in the USA and prohibited in sport under WADA S1.

Is M-Sten the same as Superdrol?

No, but they are close relatives. Superdrol is methasterone; M-Sten is methylstenbolone, which differs by a double bond at the 1 position. Both are 17-alpha-methylated and both appear in the cholestatic liver injury case literature.

Is M-Sten a SARM?

No. It is a 17-alpha-methylated steroidal compound. SARMs are non-steroidal.

What has the research found about liver effects?

Published case reports describe cholestatic jaundice in men who took products labelled as methylstenbolone, consistent with the class effect of 17-alpha-methylated steroids. No controlled human safety study exists.

Is every batch tested?

Yes. Every batch is independently tested and its certificate of analysis is published on the product page and the Lab Testing page.

Key references

Cavalcanti G de A et al. Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites. Steroids 2013;78:228-233.

Geldof L et al. In vitro metabolism study of methylstenbolone. Drug Testing and Analysis 2014 to 2016 (Ghent and Cologne laboratories).

Case series of cholestatic liver injury associated with methylstenbolone and methasterone products: Hepatology, Journal of Clinical Gastroenterology and Clinical Toxicology, 2012 to 2020.

Rahnema CD et al. Designer steroids: over-the-counter supplements and their androgenic component. Fertility and Sterility 2015;103:1271-1279.

WADA Prohibited List 2026, S1.1. Designer Anabolic Steroid Control Act 2014 (USA).

Related guides

Research products: Alpha Labs M-Sten 5mg, 90 capsules · Alpha Labs Epistane · Alpha Labs Trenavar · PCT and Cycle Support · Lab Testing

Alpha Labs Methylstenbolone M-Sten 5mg 90 Capsules
Research this compound
5mg · 90 caps. Batch certificate published.
This guide summarises published research and is for laboratory reference only. Products are not for human consumption.
All guides